Evidence map›Paper›PMID 27034466›Full record

ArticleNucleic acids research2016

Genome-wide analysis of Musashi-2 targets reveals novel functions in governing epithelial cell migration.

Christopher G Bennett, Kent Riemondy, Douglas A Chapnick, Eric Bunker, Xuedong Liu, Scott Kuersten, Rui Yi

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 64 citations in OpenAlex.

  1. Isoform-Specific Localization Diversifies Human MSI2 Function.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer.bioRxiv : the preprint server for biology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Christopher G BennettDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA.
Kent RiemondyDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA.
Douglas A ChapnickDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA.
Eric BunkerDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA.
Xuedong LiuDepartment of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309, USA.
Scott KuerstenIllumina Inc., 5602 Research Park Blvd. Suite 200, Madison, WI 53719, USA.
Rui YiDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA yir@colorado.edu.
University of Colorado Boulder · USIllumina (United States) · US

Funding

TRAINING IN SIGNAL TRANSDUCTION &CELL CYCLE REGULATIONT32GM008759 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI AHN, NATALIE G. · 2000 to 2020
$5.9M
MicroRNA-mediated Regulation in Mammalian SkinR01AR059697 · NIAMS · UNIVERSITY OF COLORADO · PI YI, RUI · 2010 to 2020
$3.9M
Genetic Analysis of MicroRNA Functions in Skin Stem Cells In VivoR01AR066703 · NIAMS · UNIVERSITY OF COLORADO · PI YI, RUI · 2014 to 2024
$3.9M
Predoctoral Training Program in Signaling and Cellular Regulation INCLUDE Down Syndrome SupplementT32GM142607 · NIGMS · UNIVERSITY OF COLORADO · PI Sabrina Leigh Spencer, Tin Tin Su · 2021 to 2026
$3.6M
Quantitative Analysis of Mechanochemical Signaling in Wound ResponseR01AR068254 · NIAMS · UNIVERSITY OF COLORADO · PI LIU, XUEDONG · 2015 to 2021
$1.8M
ImageXpress Micro Cellular Imagining and Analysis SystemS10RR026680 · NCRR · UNIVERSITY OF COLORADO · PI LIU, XUEDONG · 2011 to 2011
$380k
NCRR NIH HHS S10 RR026680NIAMS NIH HHS R01 AR059697NIAMS NIH HHS R01 AR066703NIAMS NIH HHS R01 AR068254NIGMS NIH HHS T32 GM008759NIGMS NIH HHS T32 GM142607
6 · The paper itself

Abstract

The Musashi-2 (Msi2) RNA-binding protein maintains stem cell self-renewal and promotes oncogenesis by enhancing cell proliferation in hematopoietic and gastrointestinal tissues. However, it is unclear how Msi2 recognizes and regulates mRNA targets in vivo and whether Msi2 primarily controls cell growth in all cell types. Here we identified Msi2 targets with HITS-CLIP and revealed that Msi2 primarily recognizes mRNA 3'UTRs at sites enriched in multiple copies of UAG motifs in epithelial progenitor cells. RNA-seq and ribosome profiling demonstrated that Msi2 promotes targeted mRNA decay without affecting translation efficiency. Unexpectedly, the most prominent Msi2 targets identified are key regulators that govern cell motility with a high enrichment in focal adhesion and extracellular matrix-receptor interaction, in addition to regulators of cell growth and survival. Loss of Msi2 stimulates epithelial cell migration, increases the number of focal adhesions and also compromises cell growth. These findings provide new insights into the molecular mechanisms of Msi2's recognition and repression of targets and uncover a key function of Msi2 in restricting epithelial cell migration.

Indexed as

Gene Expression RegulationRNA Stability3' Untranslated RegionsAnimalsBinding SitesCell MovementCell ProliferationCell SurvivalGenome-Wide Association StudyHigh-Throughput Nucleotide SequencingImmunoprecipitationKeratinocytesMiceRNA-Binding ProteinsRNA, MessengerSequence Analysis, RNA3' Untranslated RegionsMsi2h protein, mouseRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID27034466
PMCPMC4857000
OpenAlexW2320443335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.